Table 4.
Univariate and multivariate variables of heart failure hospitalisation 1 year after TAVI
| Univariate analysis | Multivariate analysis | |||
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age≥85 (median) | 1.03 (0.42 to 2.41) | 0.94 | ||
| Women | 0.88 (0.37 to 2.23) | 0.78 | ||
| BMI≤22.2 kg/m2 (median) | 0.52 (0.21 to 1.23) | 0.14 | ||
| Clinical frailty scale≥4 | 5.15 (2.01 to 15.8) | < 0.01 | 2.22 (0.84 to 6.36) | 0.11 |
| STS risk score≥5.9 (median) | 3.75 (1.47 to 11.5) | < 0.01 | 3.26 (1.3 to 8.15) | 0.01 |
| Hgb/Cre≤10.4 | 3.86 (1.65 to 9.48) | < 0.01 | 2.62 (1.04 to 6.88) | 0.04 |
| Diabetes mellitus | 1.25 (0.44 to 3.09) | 0.66 | ||
| Previous PCI | 1.43 (0.50 to 3.56) | 0.56 | ||
| Atrial fibrillation | 3.47 (1.46 to 8.16) | 0.01 | 3.26 (1.3 to 8.15) | 0.01 |
| Heart failure hospitalisation | 3.40 (1.42 to 8.99) | 0.01 | 2.22 (0.84 to 6.36) | 0.11 |
| Moderate or severe AR | 1.72 (0.60 to 4.20) | 0.29 | ||
| General anaesthesia | 1.88 (0.81 to 4.60) | 0.14 | ||
| Transfemoral approach | 0.42 (0.19 to 1.12) | 0.12 | ||
| Blood transfusion | 3.33 (1.40 to 7.82) | 0.01 | 3.85 (1.51 to 9.92) | 0.01 |
Values are mean±SD deviation or n (%), unless otherwise specified.
AR, aortic valve regurgitation; BMI, body mass index; Cr, creatinine; Hgb, haemoglobin; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons; TAVI, transcatheter aortic valve implantation.